BAMCO INC /NY/

Position in VKTX — Viking Therapeutics, Inc.

CIK 1017918 NEW YORK, NY

Position in VKTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,083,314

-$343,279 QoQ

Shares Held

125,486

-0.3% QoQ

Ownership

0.108%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BAMCO INC /NY/ holds $232,883,646 across 22 Biotechnology names. VKTX ranks #6 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	138,648	$101,247,702
2	ZLAB	Zai Lab Ltd	1,658,318	$31,192,961
3	TECH	BIO-TECHNE Corp	561,441	$29,340,906
4	ARQT	Arcutis Biotherapeutics, Inc.	1,072,189	$25,260,772
5	SPRY	ARS Pharmaceuticals, Inc.	1,273,341	$10,224,928
6	VKTX	Viking Therapeutics, Inc. This page	125,486	$4,083,314
7	MANE	Veradermics, Inc	59,668	$3,768,034
8	ROIV	Roivant Sciences Ltd.	125,000	$3,462,500

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,083,314	125,486	-0.3%	Shares	Defined	2026-05-15
2025-12-31	$4,426,593	125,827	-0.7%	Shares	Defined	2026-02-17
2025-09-30	$3,330,648	126,737	0.0%	Shares	Defined	2025-11-14
2025-06-30	$3,358,530	126,737	-68.5%	Shares	Defined	2025-08-14
2025-03-31	$9,713,299	402,207	+4.3%	Shares	Defined	2025-05-15
2024-12-31	$15,511,393	385,472	-18.8%	Shares	Defined	2025-02-14
2024-09-30	$30,049,711	474,644	-5.6%	Shares	Defined	2024-11-14
2024-06-30	$26,654,435	502,819	+1.9%	Shares	Defined	2024-08-14
2024-03-31	$40,447,238	493,259	+59.1%	Shares	Defined	2024-05-15
2023-12-31	$5,770,346	310,067	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.